Acquisitions boost Alliance growth
Alliance Imaging CEO Richard Zehner is looking for acquisitionsto buttress the Orange, CA, company's claim that it is the nation'slargest mobile MRI and CT fleet. Alliance announced record third-quarter earnings and strong revenueresults on Oct. 17,
Alliance Imaging CEO Richard Zehner is looking for acquisitionsto buttress the Orange, CA, company's claim that it is the nation'slargest mobile MRI and CT fleet.
Alliance announced record third-quarter earnings and strong revenueresults on Oct. 17, five days after revealing that it had takendelivery of a GE 1-tesla Signa MRI to be deployed on a new routein Missouri.
For the third quarter (end-September), Alliance reported netincome of $1.4 million on revenues of $15.1 million. For the firstnine months of 1995, Alliance earned $3.6 million on revenuesof $44.3 million.
In the third quarter of last year, the company had a net lossof $1.4 million on revenues of $14.2 million. For the first ninemonths of 1994, it posted a net loss of $3.5 million on revenuesof $42.9 million.
Alliance also ended the period with a cash balance of over $10million, which in part is earmarked to buy competing mobile companies,according to Zehner.
"We're actively seeking and evaluating corporate acquisitionsto generate higher profitability and revenues from greater marketshare," he said.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
